PACB
NASDAQ
US
Pacific Biosciences of California, Inc. - Common Stock
$1.34
▼ $-0.01
(-0.74%)
Vol 6.5M
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$564.6M
ROE
-289.5%
Margin
-325.8%
D/E
1787.64
Beta
2.28
52W
$1–$3
Wall Street Consensus
16 analysts · Apr 20264
Strong Buy
5
Buy
6
Hold
1
Sell
0
Strong Sell
56.2%
Buy Rating
Price Chart
Similar Stocks
CTKB
Cytek Biosciences Inc
$645.7M
MLAB
Mesa Laboratories Inc
$433.5M
CYRX
Cryoport Inc
P/E 7.1
$480.7M
MRVI
Maravai LifeSciences Holdings Inc
$831.0M
NAUT
Nautilus Biotechnology Inc
$246.3M
LAB
Standard BioTools Inc
$492.2M
OABI
OmniAb Inc
$266.3M
ATLN
Atlantic International Corp
$77.8M
QTRX
Quanterix Corp
$297.1M
TKNO
Alpha Teknova Inc
$203.4M
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.15 | $-0.12 | +$0.03 |
| Sep 2025 | $-0.16 | $-0.13 | +$0.03 |
| Jun 2025 | $-0.17 | $-0.14 | +$0.03 |
| Mar 2025 | $-0.19 | $-1.44 | $-1.25 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -189.2% | -189.2% | -189.2% | -189.2% | -289.5% | -289.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -105.4% | -337.2% | -337.2% | -337.2% | -325.8% | -325.8% |
| Gross Margin | 37.0% | 24.0% | 24.0% | 24.0% | 30.9% | 30.9% |
| D/E Ratio | 1051.30 | 1051.30 | 1051.30 | 1051.30 | 1787.64 | 1787.64 |
| Current Ratio | 6.92 | 6.92 | 6.92 | 6.92 | 6.24 | 6.24 |
Key Ratios
ROA (TTM)
-53.7%
P/S (TTM)
3.65
P/B
1.0
EPS (TTM)
$-1.69
CF/Share
$-1.22
Rev Growth 3Y
+5.7%
52W High
$2.73
52W Low
$0.85
$0.85
52-Week Range
$2.73
How does PACB compare to Life Sciences Tools & Services peers?
Peer group: Small-cap Life Sciences Tools & Services ($300M+) · 25 companies
PACB valuation vs Life Sciences Tools & Services peers
P/E ratio
—
▼
0%
below
peers
(32.5)
vs Peers
vs Industry
Fair value
P/S ratio
3.7
▼
4%
below
peers
(3.8)
vs Peers
vs Industry
Fair value
P/B ratio
1.0
▼
73%
below
peers
(3.7)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
PACB profitability vs Life Sciences Tools & Services peers
ROE
-289.5%
▼
8754%
below
peers
(-3.3%)
vs Peers
vs Industry
Weak
Net margin
-325.8%
▼
3370%
below
peers
(-9.4%)
vs Peers
vs Industry
Weak
Gross margin
31.0%
▼
36%
below
peers
(48.0%)
vs Peers
vs Industry
Weak
ROA
-53.7%
▼
1966%
below
peers
(-2.6%)
vs Peers
vs Industry
Weak
PACB financial health vs Life Sciences Tools & Services peers
D/E ratio
1787.6
▲
4796%
above
peers
(36.5)
vs Peers
vs Industry
High debt
Current ratio
6.2
▲
85%
above
peers
(3.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.3
▲
60%
above
peers
(1.4)
vs Peers
vs Industry
More volatile
PACB fundamentals radar
PACB
Peer median
Industry
PACB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PACB vs peers: key metrics
Latest News
No related news yet